Just got this update via BCLI's Facebook, go to youtube and search "Vice ALS Episode" - its' 27 mins long, amazing, and mentions Nurown as one of the only treatments currently in trial.
Thank's for your insight I think the same way as you do now we can and should learn from past experiences I to have sold to early at times like selling intel that I purchased in1984 after listening to my Merrill Lynch broker.
i have held onto shares for as long as 16 years when they were taken from me on pennies on the Dollar by Thermo Electron Corp.I feel I was cheated until this day .. I have learned quite a bit from all the mistakes I have made over the years . .
I remember the feeling as a new shareholder of ACADIA Pharma going into the release of their trial results late November 2012. The shares closed at $2.30 on Nov 26 and the next day more than doubled, never going below prior levels. I sold on Nov 27, but my +100% gain turned out to be my worst sell ever since $ACAD shares continued to rise all the way up to $30 within 10 months, and peaked at $50 in July of last year. Now as a holder of $BCLI shares, at almost the same share price as $ACAD was back then, it feels almost the same. You kinda knew going into the release of the trial results that the results would be good, based on the results of the prior trials. Yet very few shares of $ACAD traded on a daily basis, similar to how $BCLI trades now. Both companies have treatments for unmet needs, and prior to their big release of information neither company was widely known by traders and investors. But the big difference with Brainstorm compared to ACADIA is their ALS treatment compared to ACADIA's Parkinson's psychosis treatment is the difference between life and early death.
Seeing how $ACAD shares continued to rise once the need for their treatment was realized can be a good measure for how sharply $BCLI shares will move. It took some education on Parkinson's disease and the benefit for ACADIA's treatment to register in people's minds before the stock began to get bought up to $30/share and then $50/share, again starting from $2.30 pre-result date. As for ALS, and the worldwide knowledge of the disease, and the urgent need for a life-saving treatment there will be no shortage of thirst for $BCLI shares when Brainstorm's results are widely known. Now at the time in 2012 ACADIA released phase 3 trial results and Brainstorm will be releasing only their phase 2 numbers, but comparisons for share rise can be made when you consider the life-or-death type of urgency to push forward with an ALS treatment that could save lives.
i expect a deal will be announced with an investment in Brainstorm possibly from one of the big names .Brainstorm is an open end opportunity if they can just deliver on their promise we all will be very happy ! I personally believe Brainstorm will have good news that will confirm the prior studies at Hadassah hospital .
Blue skies ahead for Brainstorm ! Soon Brainstorm should be moving up to the major league in my humble opinion !
just came across article poblished in an israeli newspaper dated 30/6/15/
this article indicating that there is a trail taking place in hadassa hospitel begining at 3/15 to treat ms with stem cells injected to the spine and to the arm. it indicates that althoght its a privete funding , the thechnology of growing the cells is in coporation with brainstorm. its says there that this is a large scale double blinde trail that sould take between a year to 15 months 'it means that results are coming soon!!!!!!!!!!
its also indicats that early treatments before the trail show strong indications of impruvment
Google vice als and you can see a preview of the episode but you need a HBO sub to wstch the entire thing. It's great
Does anyone have any thoughts about this episode where the reporter cries about not being able to get in to brainstorm's clinical trials ? Pretty intense stuff.
Hear Me out…If you are trying to become a serious trader then you NEED to research LionStockAlerts. They have send me some solid trades recently.
very interesting and optimistic view !!! . the current share price is realy cheap
Sentiment: Strong Buy